A case of pseudoprogression in avelumab maintenance therapy for metastatic bladder cancer

INTRODUCTION: A unique phenomenon of immune therapy is pseudoprogression; however, a definite mechanism and predictive factors remain unclear. We herein report a case of pseudoprogression with avelumab maintenance therapy. CASE PRESENTATION: A 67‐year‐old male diagnosed with muscle‐invasive bladder...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayakawa, Nozomi, Kikuchi, Eiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807330/
https://www.ncbi.nlm.nih.gov/pubmed/36605694
http://dx.doi.org/10.1002/iju5.12510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807330/
https://www.ncbi.nlm.nih.gov/pubmed/36605694
http://dx.doi.org/10.1002/iju5.12510

Ejemplares similares